Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie W Rutten

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Journal of the American Society for Mass Spectrometry|September 16, 2015
In-Depth Characterization of Protein Disulfide Bonds by Online Liquid Chromatography-Electrochemistry-Mass SpectrometryLinda Switzar, Simone Nicolardi, Julie W Rutten, et al.
Expert Review of Molecular Diagnostics|May 22, 2014
Interpretation of NOTCH3 mutations in the diagnosis of CADASILJulie W Rutten, Joost Haan, Gisela M Terwindt, et al.
Stroke|March 18, 2022
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Family Members With a Pathogenic <i>NOTCH3</i> Variant Can Have a Normal Brain Magnetic Resonance Imaging and Skin Biopsy Beyond Age 50 YearsRemco J Hack, Gido Gravesteijn, Minne N Cerfontaine, et al.
Stroke|November 9, 2020
Cysteine-Altering <i>NOTCH3</i> Variants Are a Risk Factor for Stroke in the Elderly PopulationRemco J Hack, Julie W Rutten, Thomas N Person, et al.
Brain : a Journal of Neurology|December 19, 2022
Three-tiered EGFr domain risk stratification for individualized NOTCH3-small vessel disease predictionRemco J Hack, Gido Gravesteijn, Minne N Cerfontaine, et al.
Annals of Clinical and Translational Neurology|November 16, 2016
Archetypal <i>NOTCH3</i> mutations frequent in public exome: implications for CADASILJulie W Rutten, Hans G Dauwerse, Gido Gravesteijn, et al.
Neuropathology and Applied Neurobiology|July 23, 2021
NOTCH3 variant position is associated with NOTCH3 aggregation load in CADASIL vasculatureGido Gravesteijn, Remco J Hack, Aat A Mulder, et al.
European Journal of Pediatrics|October 27, 2023
Reanalysis of whole-exome sequencing (WES) data of children with neurodevelopmental disorders in a standard patient care contextMichelle van Slobbe, Arie van Haeringen, Lisenka E L M Vissers, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 22, 2018
Correction: The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1-6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7-34 pathogenic variantJulie W Rutten, Bastian J Van Eijsden, Marco Duering, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 10, 2026
NOTCH3 CADASIL Variant Receptor Aggregation Requires NOTCH3 Wild-Type Receptors: Identification of Highly Selective Inhibitors That Block the ProcessHaijiang Wang, Xinxin Liu, Gido Gravesteijn, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Journal of the American Society for Mass Spectrometry|September 16, 2015
In-Depth Characterization of Protein Disulfide Bonds by Online Liquid Chromatography-Electrochemistry-Mass SpectrometryLinda Switzar, Simone Nicolardi, Julie W Rutten, et al.
Expert Review of Molecular Diagnostics|May 22, 2014
Interpretation of NOTCH3 mutations in the diagnosis of CADASILJulie W Rutten, Joost Haan, Gisela M Terwindt, et al.
Stroke|March 18, 2022
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Family Members With a Pathogenic <i>NOTCH3</i> Variant Can Have a Normal Brain Magnetic Resonance Imaging and Skin Biopsy Beyond Age 50 YearsRemco J Hack, Gido Gravesteijn, Minne N Cerfontaine, et al.
Stroke|November 9, 2020
Cysteine-Altering <i>NOTCH3</i> Variants Are a Risk Factor for Stroke in the Elderly PopulationRemco J Hack, Julie W Rutten, Thomas N Person, et al.
Brain : a Journal of Neurology|December 19, 2022
Three-tiered EGFr domain risk stratification for individualized NOTCH3-small vessel disease predictionRemco J Hack, Gido Gravesteijn, Minne N Cerfontaine, et al.
Annals of Clinical and Translational Neurology|November 16, 2016
Archetypal <i>NOTCH3</i> mutations frequent in public exome: implications for CADASILJulie W Rutten, Hans G Dauwerse, Gido Gravesteijn, et al.
Neuropathology and Applied Neurobiology|July 23, 2021
NOTCH3 variant position is associated with NOTCH3 aggregation load in CADASIL vasculatureGido Gravesteijn, Remco J Hack, Aat A Mulder, et al.
European Journal of Pediatrics|October 27, 2023
Reanalysis of whole-exome sequencing (WES) data of children with neurodevelopmental disorders in a standard patient care contextMichelle van Slobbe, Arie van Haeringen, Lisenka E L M Vissers, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 22, 2018
Correction: The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1-6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7-34 pathogenic variantJulie W Rutten, Bastian J Van Eijsden, Marco Duering, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 10, 2026
NOTCH3 CADASIL Variant Receptor Aggregation Requires NOTCH3 Wild-Type Receptors: Identification of Highly Selective Inhibitors That Block the ProcessHaijiang Wang, Xinxin Liu, Gido Gravesteijn, et al.
Pageof 4